Shockwave shares are trading higher Tuesday following a report suggesting Johnson & Johnson is in talks to acquire the company. People familiar with the matter say that a deal to acquire the company ...

Shares of Shockwave Medical SWAV are up almost 15% so far this week. Majority of this gain is likely due to acquisition rumors. According to a report by the Wall Street Journal, Johnson & Johnson JNJ ...

Shares of Shockwave Medical (NASDAQ: SWAV) were up 10.69% early Tuesday afternoon after the Centers for Medicare and Medicaid Services (CMS) unveiled a proposed rule that detailed new payment codes ...

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the ...

SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV) (“Shockwave Medical”) announced today the pricing of its offering of $650.0 million aggregate principal amount of ...

As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...

Johnson & Johnson is moving to expand its position in cardiovascular intervention with the acquisition of California-based Shockwave Medical Inc. J&J and the target announced a definitive agreement ...

Johnson & Johnson acquired medtech company Shockwave Medical for $13.1 billion, the pharma giant announced Friday morning. The deal, which has been approved by the board of directors of both companies ...

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...

Shockwave Medical's Q2 results exceeded revenue expectations but fell short on earnings. The bottom-line shortfall came amid acquisition expenses and headcount expansion to support growth. The company ...